두경부암의 항암화학요법
Chemotherapy of Head and Neck Cancer
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Head and neck cancers comprise a heterogenous group of cancers that require a multidisciplinary approach. Surgery, radiation therapy, chemotherapy and, more recently, target therapy are often employed in various combinations in an attempt to eradicate both clinically apparent and occult disease. The role of chemotherapy in multimodality treatment for locally advanced head and neck squamous cell carcinoma, although firmly established, presents several unresolved issues. Concomitant platinum-based chemoradiation (CRT) is a standard treatment for unresectable, resectable but nonsurgically treated, and postoperative high-risk patients with locally advanced head and neck squamous cell carcinoma. Cetuximab administered concomitantly with radiotherapy has not been directly compared with CRT but offers a potential different approach using a noncytotoxic systemic agent. In recent years taxanes have been shown activity in head and neck cancers and are being incorporated into neo-adjuvant and concomitant chemotherapy regimens. Korean J Otorhinolaryngol-Head Neck Surg 2014;57(5):291-6
Abstract
Head and neck cancers comprise a heterogenous group of cancers that require a multidisciplinary approach. Surgery, radiation therapy, chemotherapy and, more recently, target therapy are often employed in various combinations in an attempt to eradicate both clinically apparent and occult disease. The role of chemotherapy in multimodality treatment for locally advanced head and neck squamous cell carcinoma, although firmly established, presents several unresolved issues. Concomitant platinum-based chemoradiation (CRT) is a standard treatment for unresectable, resectable but nonsurgically treated, and postoperative high-risk patients with locally advanced head and neck squamous cell carcinoma. Cetuximab administered concomitantly with radiotherapy has not been directly compared with CRT but offers a potential different approach using a noncytotoxic systemic agent. In recent years taxanes have been shown activity in head and neck cancers and are being incorporated into neo-adjuvant and concomitant chemotherapy regimens. Korean J Otorhinolaryngol-Head Neck Surg 2014;57(5):291-6
참고문헌 (28)
- 태경, "두경부 편평세포암종에서 선행항암화학요법과연속적 화학방사선 동시요법", 대한이비인후과학회지 두경부외과학, 50(4), pp.327~334 (2007), 대한이비인후과학회
- 이병주, "구개편도암에서 선행항암화학요법과 방사선치료의 치료성적", 대한이비인후과학회지 두경부외과학, 45(10), pp.1004~1009 (2002), 대한이비인후과학회
- Nwizu T, "The role of chemotherapy in locally advanced head and neck squamous cell carcinoma", Semin Radiat Oncol, 22(3), pp.198~206 (2012)
- Bhide SA, "Advances in chemotherapy for head and neck cancer", Oral Oncol, 46(6), pp.436~438 (2010)
- Burri RJ, "Concurrent chemotherapy and radiotherapy for head and neck cancer", Expert Rev Anticancer Ther, 9(3), pp.293~302 (2009)
- Ma J, "Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis", Oral Oncol, 48(11), pp.1076~1084 (2012)
- 이종훈, "Adjuvant Postoperative Radiotherapy with or without Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Importance of Patient Selection for the Postoperative Chemoradiotherapy", Cancer Research and Treatment, 45(1), pp.31~39 (2013), 대한암학회[DOI]
- Hyoung Sam Kim, "5-Fluorouracil and Cisplatin (FP) with Concurrent Radiotherapy for Locally Advanced Head and Neck Cancer", Cancer Research and Treatment, 34(4), pp.296~301 (2002), 대한암학회
- 최영진, "국소 진행성 두경부암 환자에서 docetaxel과 cisplatin을 이용한 유도 화학요법", 대한내과학회지, 73(4), pp.415~422 (2007), 대한내과학회
- Chandana SR, "Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects", Curr Opin Oncol, 21(3), pp.218~223 (2009)
- Specenier PM, "Current concepts for the management of head and neck cancer: chemotherapy", Oral Oncol, 45(4-5), pp.409~415 (2009)
- Molin Y, "Current chemotherapies for recurrent", metastatic head and neck cancer, 2011, pp.22(7), 621~625
- de Andrade DA, "Treatment options for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, who progress after platinum-based chemotherapy", Curr Opin Oncol, 24(3), pp.211~217 (2012)
- Takes RP, "Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery", Head Neck, 34(2), pp.270~281 (2012)
- Shin DM, "Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck", Head Neck, 35(3), pp.443~453 (2013)
- Brockstein BE, "Management of recurrent head and neck cancer:recent progress and future directions", Drugs, 71(12), pp.1551~1559 (2011)
- Purohit S, "Systemic Therapy in Head and Neck Cancer: Changing Paradigm", Indian J Surg Oncol, 4(1), pp.19~26 (2013)
- Peyrade F, "Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: review of the literature and proposal for management changes", Oral Oncol, 49(6), pp.482~491 (2013)
- Machiels JP, "Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck", Expert Rev Anticancer Ther, 11(3), pp.359~371 (2011)
- Specenier P, "Advances in the systemic treatment of head and neck cancers", Curr Opin Oncol, 22(3), pp.200~205 (2010)
- Ramos M, "Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations", Expert Rev Anticancer Ther, 10(3), pp.339~344 (2010)
- 태경, "하인두암의 치료성적: 수술 또는 기관보존요법", 대한이비인후과학회지 두경부외과학, 52(8), pp.688~694 (2009), 대한이비인후과학회
- 왕수건, "하인두암에서 선행항암화학요법 후 방사선치료의 의의", 대한이비인후과학회지 두경부외과학, 46(12), pp.1058~1063 (2003), 대한이비인후과학회
- Chan JY, "Current management strategy of hypopharyngeal carcinoma", Auris Nasus Larynx, 40(1), pp.2~6 (2013)
- 김종승, "하인두암의 치료방법에서 Docetaxel과 Platinum을 이용한 선행항암화학요법의 효과분석", 대한이비인후과학회지 두경부외과학, 53(11), pp.706~711 (2010), 대한이비인후과학회
- 김연실, "Radiation Therapy Combined with (or without) Cisplatin-based Chemotherapy for Patients with Nasopharyngeal Cancer: 15-years Experience of a Single Institution in Korea", Cancer Research and Treatment, 40(4), pp.155~163 (2008), 대한암학회
- 공일승, "비인강암의 치료방법에서 Docetaxel과 Platinum을 이용한 유도항암요법의 효과", 대한이비인후과학회지 두경부외과학, 51(1), pp.58~63 (2008), 대한이비인후과학회
- Loo SW, "Functional organ preservation in locally advanced laryngeal squamous cell carcinoma: is there a role for induction chemotherapy?", Clin Oncol (R Coll Radiol), 25(5), pp.298~307 (2013)